SARS-CoV-2 Main Protease Substrate
SARS-CoV-2 main protease Mpro (3CLpro) represents a major target in drug development against COVID-19. BIOSYNTAN offers a fluorogenic FRET substrate for activity determination and inhibitor screening of Mpro protease :
The enzymatic assay was developed by the Hilgenfeld group [1,2]. It takes advantage of a convenient read out of the fluorescent cleavage product (excitation at 340 nm / emission at 490 nm).
 L. Zhang, R. Hilgenfeld et al., J. Med. Chem., 2020, 63, 4562-4578.
 L. Zhang, R. Hilgenfeld et al., Chem. & Biol., 2008, 15, 597-606.